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Background
Charcot Neuroarthropathy (CN) is a major foot compli-
cation of diabetes which may lead to debilitating foot
deformity, recurrent ulceration and lower limb amputa-
tion. Podiatrists play a key role along the continuum of
the disease from diagnosis to treatment to long-term
follow-up and monitoring. The aim of this clinical audit
was to gather data on patients managed with active CN
in a tertiary hospital podiatry department.
Methods
Thirty cases (26 patients) were diagnosed with active
CN during the four-year period January 2005 to Decem-
ber 2008, and managed through the Royal Perth Hospi-
tal Podiatry Department. Data was retrospectively
collected from their medical records including demo-
graphics, diabetes parameters, CN treatment and out-
comes at twelve months.
Results
Seventy three percent of cases were male. Average age
55 ± 8.6 years. Sixty percent had Type 2 insulin-requir-
ing diabetes. Diabetes duration greater than 10 years in
83.3% cases. Diabetes control was poor (HbA1c 9 ±
1.9%). The most common locations of CN were the tar-
sometatarsal joints and midfoot. Seventeen percent of
cases were re-activated CN. Although 40% of cases were
accurately diagnosed within 4 weeks, 33% took over
2 months. Overall CN management time was 44.7 ±
25.3 weeks. Of cases (67%) which went into a total con-
tact cast (TCC), the overall management time was 39.3
± 29.6 weeks versus 57.5 ± 33.6 weeks for those patients
who never received TCC as part of their management.
Forty seven percent developed a foot ulcer within 12
months following stabilisation of their CN, and one case
went on to trans-tibial amputation.
Conclusions
These results provide an estimate for patients and prac-
titioners as to the overall treatment time of active CN.
Our findings suggest that management of CN can be
prolonged, but overall treatment is reduced through the
use of TCC. Despite increased awareness and education,
disparity still exists for rapid diagnosis of CN. Patients
are at risk of CN related foot ulceration despite close
monitoring in a tertiary hospital, however, are at a rela-
tively low risk of amputation on the short-term. The
audit highlights CN is a potentially recurrent condition
and patients require lifelong care and monitoring.
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